Ausgabe 4/2021
Inhalt (29 Artikel)
How has COVID-19 affected the treatment of osteoporosis? An IOF-NOF-ESCEO global survey
N. R. Fuggle, A. Singer, C. Gill, A. Patel, A. Medeiros, A. S. Mlotek, D. D. Pierroz, P. Halbout, N. C. Harvey, J.-Y. Reginster, C. Cooper, S. L. Greenspan
COVID-19 and effects on osteoporosis management: the patient perspective from a National Osteoporosis Foundation survey
A.J. Singer, N.R. Fuggle, C.B. Gill, A.R. Patel, A.P. Medeiros, S.L. Greenspan
Postpartum bilateral sacral stress fracture without osteoporosis—a case report and literature review
Y. F. Wu, K. Lu, C. Girgis, M. Preda, V. Preda
Dietary Inflammatory Index in relation to bone mineral density, osteoporosis risk and fracture risk: a systematic review and meta-analysis
Y. Fang, J. Zhu, J. Fan, L. Sun, S. Cai, C. Fan, Y. Zhong, Y. Li
Long-term cancer surveillance: results from the Forteo Patient Registry Surveillance Study
A. Gilsenan, D. Harris, M. Reynolds, D. McSorley, K. Midkiff, L. Jackson, B. Muldavin, N. Kellier-Steele, E. Andrews
Early clinical effects, safety, and appropriate selection of bone markers in romosozumab treatment for osteoporosis patients: a 6-month study
A. Tominaga, K. Wada, Y. Kato, H. Nishi, Y. Terayama, K. Okazaki
Addition of dexamethasone to manage acute phase responses following initial zoledronic acid infusion
F.-P. Chen, T.-S. Fu, Y.-C. Lin, Y.-J. Lin
Effects of age at estrogen replacement therapy initiation on trabecular bone score in Japanese adults with Turner syndrome
S. Saito, E. Koga, Y. Okada, T. Tsuburai, H. Yoshikata, E. Miyagi, H. Sakakibara
The association of objectively ascertained sibling fracture history with major osteoporotic fractures: a population-based cohort study
A.F. Hamad, S. Yang, L. Yan, W.D. Leslie, S.N. Morin, R. Walld, L.L. Roos, L.M. Lix
Adiposity and bone microarchitecture in the GLOW study
A.E. Litwic, L.D. Westbury, K. Ward, C. Cooper, E.M. Dennison
Males Have Higher Rates of Peri-operative Mortality Following Surgery for Osteoporotic Vertebral Compression Fracture
A. Gupta, T. Cha, J. Schwab, H. Fogel, D. Tobert, S. Cho, A. Hecht, C. M. Bono, S. Hershman
Trabecular and cortical bone involvement in rheumatoid arthritis by DXA and DXA-based 3D modelling
M.L. Brance, B.A. Pons-Estel, N.J. Quagliato, M. Jorfen, G. Berbotto, N. Cortese, J.C. Raggio, M. Palatnik, I. Chavero, J. Soldano, C. Dieguez, A. Sánchez, L. Del Rio, S. Di Gregorio, L.R. Brun
Detecting causal relationship between metabolic traits and osteoporosis using multivariable Mendelian randomization
Q. Zhang, J. Greenbaum, H. Shen, L.-J. Zhao, W.-D. Zhang, C.-Q. Sun, H.-W. Deng
Trends in hip fracture care in the Republic of Ireland from 2013 to 2018: results from the Irish Hip Fracture Database
M.E. Walsh, H. Ferris, T. Coughlan, C. Hurson, E. Ahern, J. Sorensen, L. Brent
Iron deficiency plays essential roles in the trigger, treatment, and prognosis of autosomal dominant hypophosphatemic rickets
C. Liu, X. Li, Z. Zhao, Y. Chi, L. Cui, Q. Zhang, F. Ping, X. Chai, Y. Jiang, O. Wang, M. Li, X. Xing, W. Xia
Incidence and risk factors for osteoporotic non-vertebral fracture in low-income community-dwelling elderly: a population-based prospective cohort study in Brazil. The São Paulo Ageing and Health (SPAH) study
D.S. Domiciano, L.G. Machado, C.P. Figueiredo, V.F. Caparbo, R.M. Oliveira, P.R. Menezes, R.M.R. Pereira
Exploring changes in bone mass in individuals with a chronic spinal cord injury
R. El-Kotob, B.C. Craven, L. Thabane, A. Papaioannou, J.D. Adachi, L.M. Giangregorio
Obesity is associated with early hip fracture risk in postmenopausal women: a 25-year follow-up
T. Rikkonen, R. Sund, J. Sirola, R. Honkanen, K.E.S. Poole, H. Kröger
Authors’ response to KD Stathopoulos regarding “Stop (Mis)classifying Fractures as High or Low Trauma or as Fragility Fractures”
S. R. Cummings, R. Eastell
RETRACTED ARTICLE: Comment on an article: “Osteoporosis in the age of COVID-19 patients”
O. Ć. Ibrahimagić, A. Vujadinović, Z. Ercegović, S. Kunić, Dž. Smajlović, Z. Dostović
Pelvic fragility fractures—the forgotten osteoporotic fracture!
O. Sahota, D. van Berkel, T. Ong, A. Drummond, P. Hendrick, N. Quraishi, K. Salem
Using health-economic evidence to support policy-level decision-making in Singapore—sensitivity analysis that provides further confidence in fracture probability-based cost-effective intervention thresholds
M. Chandran, G. Ganesan, K. B. Tan, J.-Y. Reginster, M. Hiligsmann
Bone health in men: still suffer the gender gap
M.M. Sirufo, L. Ginaldi, M. De Martinis
Author response: bone health in men: still suffer the gender gap
W. D. Leslie, L. M. Lix, N. Binkley
Reply to Comment on “Osteoporosis in the Age of COVID-19”
C. M. Girgis, R. J. Clifton-Bligh
Correction to: Bisphosphonates and mortality: confounding in observational studies
J. Bergman, A. Nordström, A. Hommel, M. Kivipelto, P. Nordström
Correction to: How has COVID-19 affected the treatment of osteoporosis? An IOF-NOF-ESCEO global survey
N.R. Fuggle, A. Singer, C. Gill, A. Patel, A. Medeiros, A.S. Mlotek, D.D. Pierroz, P. Halbout, N.C. Harvey, J.-Y. Reginster, C. Cooper, S.L. Greenspan